تحميل...
Comparison of outcomes following a switch from a brand to an authorized vs. independent generic drug
Authorized generics are identical in formulation to brand drugs, manufactured by the brand company but marketed as a generic. Generics, marketed by generic manufacturers, are required to demonstrate pharmaceutical and bioequivalence to the brand drug, but repetition of clinical trials is not require...
محفوظ في:
| الحاوية / القاعدة: | Clin Pharmacol Ther |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
2017
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5860648/ https://ncbi.nlm.nih.gov/pubmed/27981563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.591 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|